Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 3
2008 1
2009 4
2010 3
2011 6
2012 8
2013 5
2014 9
2015 9
2016 7
2017 13
2018 14
2019 8
2020 8
2021 9
2022 8
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M. de Koning HJ, et al. Among authors: nackaerts k. N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29. N Engl J Med. 2020. PMID: 31995683 Clinical Trial.
Lung Cancer in Belgium.
Ocak S, Tournoy K, Berghmans T, Demedts I, Durieux R, Janssens A, Moretti L, Nackaerts K, Pieters T, Surmont V, Van Eycken L, Vrijens F, Weynand B, van Meerbeeck JP. Ocak S, et al. Among authors: nackaerts k. J Thorac Oncol. 2021 Oct;16(10):1610-1621. doi: 10.1016/j.jtho.2021.07.022. J Thorac Oncol. 2021. PMID: 34561034 Free article. No abstract available.
Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis.
Franken A, Van Mol P, Vanmassenhove S, Donders E, Schepers R, Van Brussel T, Dooms C, Yserbyt J, De Crem N, Testelmans D, De Wever W, Nackaerts K, Vansteenkiste J, Vos R, Humblet-Baron S, Lambrechts D, Wauters E. Franken A, et al. Among authors: nackaerts k. J Immunother Cancer. 2022 Sep;10(9):e005323. doi: 10.1136/jitc-2022-005323. J Immunother Cancer. 2022. PMID: 36171010 Free PMC article.
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study.
Blackhall F, Jao K, Greillier L, Cho BC, Penkov K, Reguart N, Majem M, Nackaerts K, Syrigos K, Hansen K, Schuette W, Cetnar J, Cappuzzo F, Okamoto I, Erman M, Langer SW, Kato T, Groen H, Sun Z, Luo Y, Tanwani P, Caffrey L, Komarnitsky P, Reinmuth N. Blackhall F, et al. Among authors: nackaerts k. J Thorac Oncol. 2021 Sep;16(9):1547-1558. doi: 10.1016/j.jtho.2021.02.009. Epub 2021 Feb 16. J Thorac Oncol. 2021. PMID: 33607312 Free article. Clinical Trial.
Quantifying asbestos in lung tissue: what debate?
Nemery B, Nuyts V, Nackaerts K. Nemery B, et al. Among authors: nackaerts k. Eur Respir J. 2017 Jun 29;49(6):1700861. doi: 10.1183/13993003.00861-2017. Print 2017 Jun. Eur Respir J. 2017. PMID: 28663320 Free article. No abstract available.
Hotspots of malignant pleural mesothelioma in Western Europe.
Nuyts V, Nawrot T, Nemery B, Nackaerts K. Nuyts V, et al. Among authors: nackaerts k. Transl Lung Cancer Res. 2018 Oct;7(5):516-519. doi: 10.21037/tlcr.2018.10.01. Transl Lung Cancer Res. 2018. PMID: 30450289 Free PMC article. Review.
An uncommon histopathological diagnosis.
Bode H, Sciot R, Werbrouck E, Geusens E, Deroose CM, Nackaerts K. Bode H, et al. Among authors: nackaerts k. Breathe (Sheff). 2018 Dec;14(4):311-316. doi: 10.1183/20734735.027418. Breathe (Sheff). 2018. PMID: 30519297 Free PMC article.
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Kindler HL, Novello S, Bearz A, Ceresoli GL, Aerts JGJV, Spicer J, Taylor P, Nackaerts K, Greystoke A, Jennens R, Calabrò L, Burgers JA, Santoro A, Cedrés S, Serwatowski P, Ponce S, Van Meerbeeck JP, Nowak AK, Blumenschein G Jr, Siegel JM, Kasten L, Köchert K, Walter AO, Childs BH, Elbi C, Hassan R, Fennell DA. Kindler HL, et al. Among authors: nackaerts k. Lancet Oncol. 2022 Apr;23(4):540-552. doi: 10.1016/S1470-2045(22)00061-4. Lancet Oncol. 2022. PMID: 35358455 Free PMC article. Clinical Trial.
Bisphosphonates: prevention of bone metastases in lung cancer.
Decoster L, de Marinis F, Syrigos K, Hirsh V, Nackaerts K. Decoster L, et al. Among authors: nackaerts k. Recent Results Cancer Res. 2012;192:93-108. doi: 10.1007/978-3-642-21892-7_4. Recent Results Cancer Res. 2012. PMID: 22307371 Review.
110 results